Nov
DEC
Jan
19
2014
2015
2016
1 captures
19 Dec 15 - 19 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Respiratory Cancers
No Significant Difference in Treatment versus Supportive Care in Stage IV NSCLC
Benefit and Tolerance to Induction Therapy in Elderly Patients with Locally Advanced NSCLC
Progression-Free Survival Not Improved with Cabazitaxel versus Topotecan in Refractory SCLC
Randomized, Prospective Trial of Customized Neoadjuvant versus Standard Chemotherapy Gets Underway
Treating Stage I to III Non-Small-Cell Lung Cancer with Limited Evidence
Addressing Challenges in Lung Cancer Screening
Nintedanib Plus Docetaxel Improves PFS and OS for Patients with Stage IIIB/IV or Recurrent Lung Adenocarcinoma
Treatment Based on BRCA1 and RAP80 Does Not Extend PFS
PRONOUNCE Study Results
State of the Art Treatment for Lung Cancer
Pages
Previous
Next
1
2
3
4